Cargando…
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086415/ https://www.ncbi.nlm.nih.gov/pubmed/37056348 http://dx.doi.org/10.3389/fonc.2023.1180650 |